We recently published a list of Top 10 Insider Purchases Last Month. In this article, we are going to take a look at where ...

of approximately 7.5 months. A positive outcome could significantly boost investor confidence and potentially lead to a stock price increase. Arcus Biosciences is not solely relying on its HIF ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Arcus Biosciences (RCUS – Research Report), ...

If Arcus CEO Terry Rosen ... potential to address a significant unmet need for patients with an estimated $5 billion market opportunity.” The CEO pointed to updated phase 1 data presented ...

Shares of Arcus Biosciences (NYSE ... to address a significant unmet need for patients with an estimated $5 billion market opportunity,” Rosen added.

Shares of Arcus Bioscience are dropping by 5% in the pre-market trading. All shares are being offered by the company, and the offering is expected to close around February 19. Arcus plans to use ...